S&P 500: Risk Of Collapse - Week Starting 23rd October (Technical Analysis) (SP500)
By Press Room
5 Mins read
Last weekend’s article was titled “Make or Break,” and based on this week’s performance, the S&P 500 (SPY) is taking the latter…
I have been negative all year on Curaleaf (OTCPK:CURLF). Most recently, ahead of the potential rescheduling, I predicted that it could break…
Ares Capital: Rock-Solid Despite Recession Fears Heading Into Q3 Earnings (NASDAQ:ARCC)
By Press Room
3 Mins read
Ares Capital (NASDAQ:ARCC) is a leading business development company or BDC. Its market cap of $10.5B gives it a significant scale and…
United Therapeutics: Fundamental And Technical Analyses Justify A Buy Decision (UTHR)
By Press Room
7 Mins read
Investment Thesis United Therapeutics Corporation (NASDAQ:UTHR) has been in a long-term uptrend since 2019, making higher highs and higher lows. The stock…
*April 1st – Dec 31st, 2016 The compounded performance figures represent all realized and unrealized losses and gains in the firm’s brokerage…
Investment Thesis The last time I wrote about Netflix, I mentioned how the actors’ and writers’ strikes were unlikely to have an…
Enterprise Products Partners: A Strong Second Half Expected, FCF Gains Ahead (NYSE:EPD)
By Press Room
4 Mins read
High-dividend stocks have been battered on a relative basis in 2023 as rising interest rates have made big-yielders less attractive. Rebounding oil…
Ares Capital Corp (NASDAQ:ARCC) has long been my favorite overall Business Development Company (i.e., “BDC”)(BIZD), in large part due to its impressive…
ARK Invest, founded by Cathie Wood, gained significant attention in the financial world for its focus on disruptive innovation and investing in…
Alaska Air: Flying Into Troubled Market Forcing Rating Downgrade (NYSE:ALK)
By Press Room
3 Mins read
Alaska Airlines Boeing 737 Landing In April 2023, I marked Alaska Air Group (NYSE:ALK) stock a buy based on its 2023 projections….